TrialDigestive diseases and sciences2006

Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.

Kyoya Sakimura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.